Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Neoadjuvant chemotherapy followed by curative-intent surgery for perihilar cholangiocarcinoma based on its anatomical resectability classification and lymph node status

Fig. 4

Disease-specific survival (DSS) curves in the 72 patients with localized perihilar cholangiocarcinoma. (a) Comparison with DSS among R, BR, and LA: There was no statistical difference of 5-year DSS (50.3% vs. 30.0% vs. 16.5%, p = 0.136, respectively). (b) Comparison with DSS between resected (n = 49) and unresected (n = 23) patients: there was significant difference of 5-year DSS (43.8% vs. 5.9%, p < 0.001). (c) Comparison with DSS among R, BR, and LA in patients with resection: There was no statistical difference of 5-year DSS among three criteria (p = 0.873). (d) Comparison with DSS among R, BR, and LA in patients without resection: There was no statistical difference of 5-year DSS among three criteria (p = 0.053). DSS: disease-specific survival, R: resectable, BR: borderline resectable, LA: locally advanced, MST: median survival time

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us